Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

ALPNALPN
3 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in ALPINE IMMUNE SCIENCES INC

As of its Q1 2024 13F, Janus Henderson held 450,827 shares of ALPN (Alpine Immune Sciences), worth $17.8M. Janus Henderson's 13F filings listed ALPN from Q4 2023 to Q1 2024, 2 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$11.1M

Total Shares Change

-583,239

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q1
Decreased
450,827
-22.7%
$17.8M0.0%—
0
2023-Q4
New
583,239
-
$11.1M0.0%—
38

Other major holders of ALPN: Avoro Capital Advisors LLC, BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used